Why Patients Need You
Pfizers purpose is to deliver breakthroughs that change patients lives. Research and Development is at the heart of fulfilling Pfizers purpose as we work to translate advanced science and technologies into the therapies and vaccines that matter most. You will apply cutting-edge design and process development capabilities to accelerate and bring the best in class medicines to patients around the world.
Role Summary
Pfizer is currently developing COVID-19 and influenza vaccines based on mRNA technology as well as vaccines using other approaches.
In partnership with the Director of Viral Vaccines, the individual will work in the next generation of RNA vaccines and other modalities. This is a laboratory-based position in the Viral Vaccines group (Research).
Responsibilities
* Extensive molecular biology experience including cloning, sequencing analysis, DNA/RNA isolation, In vitro transcription, RT-qPCR, RNA manipulation and data analysis.
* Experience in standard cell culture techniques under BSL2 conditions including transfection, electroporationetc.
* Analysis of protein expression in cells using Western-Blot and immunofluorescence among other techniques.
* Other cell-based assays including luciferase expression, ELISA, Luminex, etc.
* Assist in all virology experiments including generation of viruses and virology assays.
Qualifications
Must-Have
* Familiarity with basic bioinformatic software tools for analyzing gene sequencing data.
* Proficiency with Microsoft Office applications and relevant scientific software, including graphing/statistical analysis tools is expected.
* Ability to work well in sight of aggressive timelines and excellence in multitasking.
* Highly organized, detail-oriented individual capable of keeping laboratory inventories up to date.
* Demonstrate curiosity and creative desire to answer scientific questions.
Education
* Degree in Molecular Biology, Biochemistry, Virology, or a related scientific field. MS with 4 years of research experience, or BS with 6 years of laboratory research experience. Industry experience preferred.
* Previous knowledge and experience working on Influenza virus is a plus.
* BSL3 experience desirable.
Other Job Details:
* Last Date to Apply for Job: January 26, 2021
* Eligible for Relocation Package: YES
* Eligible for Employee Referral Bonus: YES
LI-PFE
Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care providers name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.
Research and Development
LI-PFE
New York, New York
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names.
Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Oncolytics Biotech Inc.; licensing agreement with BionTech AG; strategic alliance with Verily Life Sciences LLC; and collaboration agreements with Pfizer, Merck & Co., Inc., and Eli Lilly & Company, as well as with Merck KGaA and Nektar Therapeutics to develop a therapy for treating pancreatic cancer. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.